The Centers for Medicare & Medicaid Services has improved Healthcare.gov since its disastrous launch in 2013, but still lacks the IT management policies to fully fix the system, according to a new report from the Government Accountability Office.
In a three-month review of cyber risk management practices in healthcare, the Health Information Trust Alliance has found that the industry's approach is reactive, inefficient and labor intensive.
Patient engagement through a remote behavioral health intervention after a cardio vascular event has the ability to reduce hospital admissions and length of hospital stays, a study published in the American Journal of Managed Care found.
An increasing number of healthcare companies say they have security and compliance policies in place for transferring data, but many also say those policies are only "moderately enforced," according to a newly published survey.
With the ICD-10 implementation deadline less than a year away, a majority of healthcare organizations will be reaching into their wallets to pay for the migration, according to a new report.
Security audits and penalties are not the way to tackle the problem of security breaches in the healthcare industry, according to Marc Probst, vice president and CIO at Salt Lake City-based Intermountain Healthcare.
After serving nearly 20 years as executive director of the North Carolina Healthcare Information & Communications Alliance, and as a board member of the National e-Health Collaborative, Holt Anderson is now heading efforts to develop the governance and policy framework required for such a learning health system. Anderson spoke with FierceHealthIT about that work.
An examination of health information exchange research published this month in Health Affairs determines that despite an increase in the sharing of health data across organizations, benefits on costs and care quality are scarce.
Evolutionary computing is beginning to have an impact on healthcare, one that will only grow, according to Robert J. Szczerba, CEO of X Tech Ventures.
The U.S. Food and Drug Administration's decision to allow 23andMe to market a genetic test directly to consumers will help further innovation, but will also open the doors for the sale of personal patient information, according to Vivek Wadhwa, a fellow at Rock Center for Corporate Governance at Stanford University.